BR0307172A - Composição farmacêutica contendo 2,2-dicloro-12-(4-clorofenil)-ácido dodecanóico - Google Patents

Composição farmacêutica contendo 2,2-dicloro-12-(4-clorofenil)-ácido dodecanóico

Info

Publication number
BR0307172A
BR0307172A BR0307172-3A BR0307172A BR0307172A BR 0307172 A BR0307172 A BR 0307172A BR 0307172 A BR0307172 A BR 0307172A BR 0307172 A BR0307172 A BR 0307172A
Authority
BR
Brazil
Prior art keywords
chlorophenyl
pharmaceutical composition
dodecanoic acid
dichloro
composition containing
Prior art date
Application number
BR0307172-3A
Other languages
English (en)
Inventor
Yasuo Shinoda
Niichiro Takano
Hiroyuki Kawashima
Toshio Inagi
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of BR0307172A publication Critical patent/BR0307172A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA CONTENDO 2,2-DICLORO-12-(4-CLOROFENIL) -áCIDO DODECANóICO)". Uma composição farmacêutica altamente estável que consiste de uma mistura contendo uma substância selecionada no grupo que consiste de 2,2-dicloro-12-(4-clorofenil)-ácido dodecanóico, seus sais e seus ésteres, e croscarmelose sódica.
BR0307172-3A 2002-01-16 2003-01-15 Composição farmacêutica contendo 2,2-dicloro-12-(4-clorofenil)-ácido dodecanóico BR0307172A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002007022 2002-01-16
PCT/JP2003/000251 WO2003059337A1 (en) 2002-01-16 2003-01-15 Medicinal composition containing 2,2-dichloro-12-(4-chlorophenyl)dodecanoic acid

Publications (1)

Publication Number Publication Date
BR0307172A true BR0307172A (pt) 2004-11-03

Family

ID=19191302

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0307172-3A BR0307172A (pt) 2002-01-16 2003-01-15 Composição farmacêutica contendo 2,2-dicloro-12-(4-clorofenil)-ácido dodecanóico

Country Status (20)

Country Link
US (1) US20060051410A1 (pt)
EP (1) EP1473033A1 (pt)
JP (1) JPWO2003059337A1 (pt)
KR (1) KR20040090975A (pt)
CN (1) CN1259909C (pt)
AU (1) AU2003201879B2 (pt)
BR (1) BR0307172A (pt)
CA (1) CA2474014A1 (pt)
EA (1) EA007650B1 (pt)
HR (1) HRP20040718A2 (pt)
IL (1) IL162880A0 (pt)
IS (1) IS7340A (pt)
MX (1) MXPA04006977A (pt)
NO (1) NO20043376L (pt)
NZ (1) NZ534471A (pt)
PL (1) PL373035A1 (pt)
TW (1) TWI252755B (pt)
UA (1) UA80270C2 (pt)
WO (1) WO2003059337A1 (pt)
ZA (1) ZA200406453B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA010020B1 (ru) * 2003-05-23 2008-06-30 Кова Компани, Лтд. Соединение карбоновой кислоты и лекарственное средство, его включающее
EP1752145A1 (en) * 2004-06-01 2007-02-14 Kowa Company Ltd. Therapeutic agent for hyperlipemia and therapeutic agent for diabetes
EP1772149A1 (en) * 2004-07-27 2007-04-11 Kowa Company. Ltd. Drug for prevention or treatment of diabetes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3586471B2 (ja) * 1991-06-25 2004-11-10 三菱ウェルファーマ株式会社 トラセミド含有医薬組成物
CA2100836C (en) * 1993-07-19 1998-02-03 Bernard Charles Sherman PHARMACEUTICAL COMPOSITION
DE4439947A1 (de) * 1994-11-09 1996-05-15 Boehringer Mannheim Gmbh 2,2-Dichloralkancarbonsäuren, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
GT200100039A (es) * 2000-03-16 2001-12-31 Pfizer Inhibidor de la glucogeno fosforilasa.

Also Published As

Publication number Publication date
MXPA04006977A (es) 2005-04-19
CN1259909C (zh) 2006-06-21
WO2003059337A1 (en) 2003-07-24
EA007650B1 (ru) 2006-12-29
UA80270C2 (en) 2007-09-10
ZA200406453B (en) 2006-06-28
CA2474014A1 (en) 2003-07-24
KR20040090975A (ko) 2004-10-27
AU2003201879B2 (en) 2007-09-13
TWI252755B (en) 2006-04-11
TW200302079A (en) 2003-08-01
EP1473033A1 (en) 2004-11-03
NZ534471A (en) 2005-08-26
EA200400954A1 (ru) 2004-12-30
PL373035A1 (en) 2005-08-08
HRP20040718A2 (en) 2004-12-31
IS7340A (is) 2004-06-30
NO20043376L (no) 2004-08-13
US20060051410A1 (en) 2006-03-09
AU2003201879A1 (en) 2003-07-30
IL162880A0 (en) 2005-11-20
CN1612730A (zh) 2005-05-04
JPWO2003059337A1 (ja) 2005-05-19

Similar Documents

Publication Publication Date Title
BR0014486A (pt) Composições farmacêuticas contendo polipeptìdeo lìquido estabilizado
IS4326A (is) Ný forðakyrni og lyfjablanda sem inniheldur þau
CO5580776A2 (es) Formulacion farmaceutica estable en solucion de oxaliplatino
BR9909565A (pt) Derivados bicìclicos do ácido hidroxâmico
BR0109943A (pt) Composições farmacêuticas
DE60019693D1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
BR9914044A (pt) ésteres tetrahidropirido
DK1273299T3 (da) Minoxidilinindeholdende praparater
BR9814523A (pt) "composição farmacêutica contendo cloridrato de bupropion e um estabilizador de ácido inorgânico"
BRPI0412697A (pt) composições farmacêuticas que apresentam um revestimento expansìvel
BRPI9916820B8 (pt) composição compreendendo 9[2[[bis[(pivaloilóxi)metil]fosfono]metóxi]etil]adenina, comprimido ou cápsula e método
BR0307172A (pt) Composição farmacêutica contendo 2,2-dicloro-12-(4-clorofenil)-ácido dodecanóico
DK0937043T3 (da) Substituerede tetrahydropyridin-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse derivater
BR0308601A (pt) inibidores de carboxipeptidase b de plasma
ATE236885T1 (de) Hydrazono-benzazulen-derivate, pharmazeutische zusammensetzungen und zwischenprodukte
DE60004204D1 (de) Pharmazeutische zusammensetzungen, bestimmt zur oralen verabreichung von phloroglucinol sowie deren herstellung
DK1409449T3 (da) Alpha-ketoglutarater af aktive ingredienser og sammensætninger omfattende disse
SE9902742D0 (sv) New pharmaceutical formultion
DK1061938T3 (da) Orale sammensætninger med cytotoksiske proteiner i lav dosis
BR0313076A (pt) Sal de ácido orgânico de amlodipina
ES2190267T3 (es) Recipiente de plastico que contiene formulaciones de farmacos estabilizadas.
DK1093451T3 (da) Faststofsammensætninger egnede til oral indgivelse indeholdende ikke-hygroskopiske salte af L-carnitin og alkanoyl-L-carnitiner
BR0101116A (pt) Composição de diluente/peróxido, sólida, de livreescoamento; e; uso de uma composição
SE9304065D0 (sv) New compound
ATE240322T1 (de) 3-imino-1,2-dithiolen derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6O E 7O ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2047 DE 30/03/2010.